Workflow
Corcept Transition To New Specialty Pharmacy Well Underway

Analyst’s Disclosure:I/we have a beneficial long position in the shares of CORT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Additional disclosure: This article expresses my personal beliefs and opinions relating to the subject matter contained in the article. Other t ...